11/14
11:31 am
glto
Galecto (GLTO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]
Low
Report
Galecto (GLTO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]
11/1
08:30 am
glto
Galecto Reports Third Quarter 2024 Financial Results
Low
Report
Galecto Reports Third Quarter 2024 Financial Results
10/17
09:39 am
glto
Galecto, Inc. (NASDAQ: GLTO) had its price target raised by analysts at Oppenheimer Holdings Inc. from $9.00 to $10.00. They now have an "outperform" rating on the stock.
Low
Report
Galecto, Inc. (NASDAQ: GLTO) had its price target raised by analysts at Oppenheimer Holdings Inc. from $9.00 to $10.00. They now have an "outperform" rating on the stock.
10/15
08:30 am
glto
Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler
Medium
Report
Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler
10/7
08:58 am
glto
Galecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge Medicines [Yahoo! Finance]
Low
Report
Galecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge Medicines [Yahoo! Finance]
10/7
08:45 am
glto
Galecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge Medicines
High
Report
Galecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge Medicines